Editorial Board
Toru Ishikawa Ph.D
Department of Gastroenterology and Hepatology, Saiseikai Niigata Second Hospital, Teraji 280-7, Niigata 950-1104, Japan · Japan
Editorial leadership for Journal of Current Chronic Diseases
Research interests
- Hepatocellular Carcinoma Liver Cirrhosis Portal Hypertension Hepatitis Ivr
Biography
Awards:
- Hepatology Research Award (The Japan Society of Hepatology2003)
Selected publications
- Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population 2023 cited 118×
- Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in hepatocellular carcinoma patients 2023 cited 52×
- Geriatric nutritional risk index as an easy‐to‐use assessment tool for nutritional status in hepatocellular carcinoma treated with atezolizumab plus bevacizumab 2023 cited 24×
- Development and validation of a modified albumin–bilirubin grade and α-fetoprotein score (mALF score) for hepatocellular carcinoma patients receiving atezolizumab and bevacizumab 2022 cited 21×
- The hepatocellular carcinoma modified Gustave Roussy Immune score (HCC‐GRIm score) as a novel prognostic score for patients treated with atezolizumab and bevacizumab: A multicenter retrospective analysis 2022 cited 20×
- Efficacy of durvalumab plus tremelimumab treatment for unresectable hepatocellular carcinoma in immunotherapy era clinical practice 2024 cited 16×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JCD for your work?
This journal is guided by Toru Ishikawa (Department of Gastroenterology and Hepatology, Saiseikai Niigata Second Hospital, Teraji 280-7, Niigata 950-1104, Japan) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.